论文部分内容阅读
目的观察美能(复方甘草酸苷)联合三氮唑核苷治疗麻疹临床疗效。方法随机将80例麻疹患者分为治疗组和对照组,治疗组:用复方甘草酸苷针静注每日1次,联合三氮唑核苷(0.1~0.6g)静注每日1次,1周1个疗程。对照组单独使用三氮唑核苷(0.1~0.6g)静注每日1次,1周1个疗程,两组治疗期间均有对症治疗。结果经Excel表格收集数据,治疗组痊愈率、显效率、好转率明显高于对照组,P(0.05。结论复方甘草酸苷联合三氮唑核苷对麻疹临床效果明显且安全,值得临床推广。
Objective To observe the clinical effect of methem (compound glycyrrhizin) and ribavirin in the treatment of measles. Methods Eighty measles patients were randomly divided into treatment group and control group. The treatment group was treated with intravenous injection of compound glycyrrhizin once daily and intravenous injection of ribavirin once daily (0.1-0.6g) 1 week 1 course of treatment. The control group was treated with ribavirin alone (0.1 ~ 0.6g) once daily for 1 week and once for 1 week. Both groups were symptomatically treated during the treatment period. Results The data were collected by Excel, and the cure rate, effective rate and improvement rate of the treatment group were significantly higher than those of the control group, P (0.05) .Conclusion Compound glycyrrhizin and ribavirin have obvious clinical effect on measles and are worthy of clinical promotion.